U.K. to be first to sell OTC Viagra; Regeneron offers startup scientific expertise; docs more likely to get poor marks when they reject patient requests
Five things for pharma marketers to know: Monday, November 27, 2017
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson’s trial
Five things for pharma marketers to know: Monday, November 13, 2017